Announcements Trials

Browse Landscape

Sponsor

Conditions

Cholangiocarcinoma 3 Glioblastoma 2 Upper Tract Urothelial Carcinomas 1 Squamous Cell Carcinoma of Head and Neck 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Papillomavirus Infections 1 Oncogenic osteomalacia 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Melanoma 1 Hypophosphatemia 1 Hematologic Neoplasms 1 Glioma 1 Breast Neoplasms 1 Advanced Gastrointestinal Stromal Tumor (GIST) 1

Interventions

Oxaliplatin 53 Cisplatin 52 Fluorouracil 50 Capecitabine 48 pembrolizumab 39 Leucovorin 31 Docetaxel 26 Trastuzumab 23 Paclitaxel 20 Irinotecan 20 Ramucirumab 13 Bevacizumab 12 Cetuximab 9 Radiotherapy 8 Surgical Procedures, Operative 7 S 1 (combination) 7 Nivolumab 7 Epirubicin 7 Carboplatin 6 olaparib 5 Platinum 5 Everolimus 5 Sunitinib 4 Mitomycin 4 trastuzumab deruxtecan 3 lenvatinib 3 epacadostat 3 bemarituzumab 3 apatinib 3 Saline Solution 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Stomach Neoplasms × infigratinib × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡